Federal Register: October 28, 2009 (Volume 74, Number 207)
DOCID: fr28oc09-114 FR Doc E9-25887
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
DOCID: fr28oc09-114
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Registration
DOCUMENT SUMMARY:
By Notice dated June 15, 2009, and published in the Federal Register on June 23, 2009, (74 FR 29720), Noramco Inc., Division of OrthoMcNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.
The company plans to bulk manufacture the above listed controlled substance for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C 823(a) and determined that the registration of
Noramco, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at
[[Page 55589]]
this time. DEA has investigated Noramco, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic class of controlled substance listed. Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925887 Filed 102709; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Manufacturer of Controlled Substances; Registrations
DOCUMENT BODY 2:
By Notice dated June 15, 2009, and published in the Federal Register on June 23, 2009, (74 FR 29720), Noramco Inc., Division of OrthoMcNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.
The company plans to bulk manufacture the above listed controlled substance for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C 823(a) and determined that the registration of
Noramco, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at
[[Page 55589]]
this time. DEA has investigated Noramco, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic class of controlled substance listed. Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925887 Filed 102709; 8:45 am]
BILLING CODE 441009P